Stephens initiated coverage of TransMedics with an Overweight rating and $151 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMDX:
- TransMedics price target raised to $120 from $95 at Piper Sandler
- TransMedics price target raised to $117 from $102 at Canaccord
- TransMedics price target raised to $125 from $105 at Oppenheimer
- TransMedics price target raised to $130 from $100 at TD Cowen
- TransMedics Reports First Quarter 2024 Financial Results